U.S. Markets close in 4 hrs 51 mins

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.98+0.14 (+0.35%)
As of 11:05AM EDT. Market open.
People also watch
Full screen
Previous Close39.84
Bid39.92 x 100
Ask40.05 x 200
Day's Range39.60 - 40.34
52 Week Range22.45 - 40.48
Avg. Volume261,331
Market Cap1.36B
PE Ratio (TTM)105.49
EPS (TTM)0.38
Earnings DateAug 2, 2017 - Aug 7, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est40.00
Trade prices are not sourced from all markets
  • Investopedia2 days ago

    Top 3 Healthcare Penny Stocks for 2017

    These three penny health care stocks are poised for a positive 2017.

  • Capital Cube3 days ago

    ETFs with exposure to Repligen Corp. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Repligen Corp. Here are 5 ETFs with the largest exposure to RGEN-US. Comparing the performance and risk of Repligen Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Repligen Corp. :RGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
    Capital Cube6 days ago

    Repligen Corp. :RGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Repligen Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Repligen Corp. – Novavax, Inc., Neurocrine Biosciences, Inc., BioMarin Pharmaceutical Inc., General Electric Company, Thermo Fisher Scientific Inc., Caladrius Biosciences, Inc., Pfizer Inc., Sangamo Therapeutics, Inc., Charles River Laboratories ... Read more (Read more...)